Dermatologic disorders
Dermatologic disorders
11/29/2016
Researchers analyzed the outcomes of patients with hidradenitis suppurativa and assess how treatment with biologic agents affects disease activity scores including Hidradenitis Sartorius Score and Hurley...
11/29/2016
Feature
Feature
08/16/2016
Hidradenitis suppurativa is a chronic disease presenting with recurrent abscesses, scarring, and sinus tract formation.
08/16/2016
Dermatologic Disorders
Dermatologic Disorders
07/27/2016
The US Preventive Services Task Force has released a new recommendation statement updating its 2009 recommendation on the screening for skin cancer, focusing on visual exams conducted by primary care...
07/27/2016
Dermatologic Disorders
Dermatologic Disorders
06/02/2016

Charles J. Haddad, MD; Judella Haddad-Lacle, MD; Reetu Grewal, MD; Lori Bilello, PhD; and Charles M. Haddad

Charles J. Haddad, MD; Judella Haddad...
The vast majority of skin growths or tumors are benign. It is very common for patients to ask their health care provider about such lesions, and they often seek advice when consulting about some other...
06/02/2016
Dermatologic Disorders
Dermatologic Disorders
05/12/2016
The FDA has warned that the antipsychotic drug, olanzapine, may be associated with a rare but serious skin reaction.
05/12/2016
Bacterial Infection
Bacterial Infection
04/01/2016
Researchers examined trends in the duration of antibiotic treatment for inflammatory or nodulocystic acne and how they compare to guidelines recommending against antibiotic overuse.
04/01/2016
Dermatologic Disorders
Dermatologic Disorders
12/18/2015
Saline water is more successful than using soap and water at cleaning wounds for open fractures, according to new research.
12/18/2015
Dermatologic Disorders
Dermatologic Disorders
12/16/2015
A new study evaluates the sufficiency of the shingles vaccine in patients with end-stage renal disease.
12/16/2015
FDA ALERT
FDA ALERT
11/08/2015

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.
11/08/2015
FDA ALERT
FDA ALERT
11/08/2015

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.
11/08/2015